HMGCR (NM_000859) Human Tagged ORF Clone Lentiviral Particle

CAT#: RC213184L2V

  • LentiORF®

Lenti ORF particles, HMGCR (mGFP-tagged)-Human 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), transcript variant 1, 200ul, >10^7 TU/mL

ORF Plasmid: DDK tGFP



Need custom lentivirus service?
Get a free quote

CNY 17,765.00


货期*
详询

规格
    • 200 ul

Product images

经常一起买 (3)
HMGCR Rabbit polyclonal Antibody
    • 100 ul

CNY 1,999.00
CNY 3,280.00

热销推荐


Lenti ORF control particles of pLenti-C-mGFP, >10^7 TU/mL, 0.5 mL
    • 500 ul

CNY 2,950.00


One-Wash Lentivirus Titer Kit, HIV-1 p24 ELISA
    • 96 reactions

CNY 5,230.00

Specifications

Product Data
Product Name HMGCR (NM_000859) Human Tagged ORF Clone Lentiviral Particle
Synonyms LDLCQ3
Vector pLenti-C-mGFP
ACCN NM_000859
ORF Size 2664 bp
Sequence Data
The ORF insert of this clone is exactly the same as(RC213184).
OTI Disclaimer The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info
OTI Annotation This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene.
Reference Data
RefSeq NM_000859.1
RefSeq Size 4471 bp
RefSeq ORF 2667 bp
Locus ID 3156
Domains HMG-CoA_red
Protein Families Druggable Genome, Transmembrane
Protein Pathways Metabolic pathways, Terpenoid backbone biosynthesis
MW 97.3 kDa
Gene Summary HMG-CoA reductase is the rate-limiting enzyme for cholesterol synthesis and is regulated via a negative feedback mechanism mediated by sterols and non-sterol metabolites derived from mevalonate, the product of the reaction catalyzed by reductase. Normally in mammalian cells this enzyme is suppressed by cholesterol derived from the internalization and degradation of low density lipoprotein (LDL) via the LDL receptor. Competitive inhibitors of the reductase induce the expression of LDL receptors in the liver, which in turn increases the catabolism of plasma LDL and lowers the plasma concentration of cholesterol, an important determinant of atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.
Customer Reviews 
Loading...